Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
J Clin Endocrinol Metab
    March 2024
  1. VAN DER VALK ES, Mohseni M, Iyer AM, van den Hurk M, et al
    Long-term glucocorticoid exposure and incident cardiovascular diseases - the Lifelines cohort.
    J Clin Endocrinol Metab. 2024 Mar 19:dgae081. doi: 10.1210.
    >> Share

  2. STOKAR J, Szalat A
    Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study.
    J Clin Endocrinol Metab. 2024 Mar 14:dgae173. doi: 10.1210.
    >> Share

  3. COSTA FC, Gomes LG, de Lima TM, Bortolotto LA, et al
    Cardiovascular risk in women with nonclassical congenital adrenal hyperplasia.
    J Clin Endocrinol Metab. 2024 Mar 11:dgae155. doi: 10.1210.
    >> Share

    February 2024
  4. CHEN GC, Hukportie DN, Liu YJ, Wang HP, et al
    Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease in Type 2 Diabetes: A UK Biobank Study.
    J Clin Endocrinol Metab. 2024 Feb 27:dgae100. doi: 10.1210.
    >> Share

  5. KIM MK, Lee KN, Han K, Lee SH, et al
    Diabetes duration, cholesterol levels, and risk of cardiovascular diseases in individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Feb 15:dgae092. doi: 10.1210.
    >> Share

    January 2024
  6. ZHU K, Geng T, Qiu Z, Li R, et al
    Beverage Consumption, Genetic Predisposition, and Risk of Cardiovascular Disease among Adults with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Jan 27:dgae050. doi: 10.1210.
    >> Share


  7. Correction to: "Childhood Obesity, Diabetes, and Cardiovascular Disease Risk".
    J Clin Endocrinol Metab. 2024 Jan 20:dgae030. doi: 10.1210.
    >> Share

    December 2023
  8. QIN Z, Muhanhali D, Ling Y
    Impaired thyroid hormone sensitivity increases risk of cardiovascular events in patients undergoing coronary angiography.
    J Clin Endocrinol Metab. 2023 Dec 16:dgad735. doi: 10.1210.
    >> Share


  9. Correction to: "Long-term Cardiovascular Disease After Adverse Pregnancy Outcomes".
    J Clin Endocrinol Metab. 2023 Dec 6:dgad692. doi: 10.1210.
    >> Share


  10. Correction to: "Reassuring Data on the Cardiovascular Risk in Adults With X-linked Hypophosphatemia Receiving Conventional Therapy".
    J Clin Endocrinol Metab. 2023 Dec 6:dgad703. doi: 10.1210.
    >> Share

    November 2023
  11. BANCKS MP, Pilla SJ, Balasubramanyam A, Yeh HC, et al
    Association of lifestyle intervention with risk for cardiovascular events differs by level of glycated hemoglobin.
    J Clin Endocrinol Metab. 2023 Nov 18:dgad674. doi: 10.1210.
    >> Share

  12. CHEN AX, Radhakutty A, Drake SM, Kiu A, et al
    Cardiovascular risk markers in adults with adrenal incidentaloma and mild autonomous cortisol secretion.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad665. doi: 10.1210.
    >> Share


  13. Correction to "Association of Circulating Very Long-Chain Saturated Fatty Acids With Cardiovascular Mortality in NHANES 2015 to 2016".
    J Clin Endocrinol Metab. 2023 Nov 2:dgad633. doi: 10.1210.
    >> Share

  14. ROSENBERG EA, Seely EW
    Long-term Cardiovascular Disease After Adverse Pregnancy Outcomes.
    J Clin Endocrinol Metab. 2023 Nov 2:dgad600. doi: 10.1210.
    >> Share

  15. YE J, Li K
    Letter to the Editor from Ye and Li: "Association of Circulating Very Long Chain Saturated Fatty Acids with Cardiovascular Mortality in NHANES 2015-2016".
    J Clin Endocrinol Metab. 2023 Nov 1:dgad647. doi: 10.1210.
    >> Share

    October 2023
  16. ZENG C, Liu M, Zhang Y, Deng S, et al
    Association of Urine Albumin-to-Creatinine Ratio with Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad645. doi: 10.1210.
    >> Share

  17. PENNA GC, Bianco AC, Ettleson MD
    A cross-sectional analysis of cardiovascular and bone healthcare utilization during treatment with thyroid hormone.
    J Clin Endocrinol Metab. 2023 Oct 25:dgad629. doi: 10.1210.
    >> Share

  18. CHAROENSRI S, Auchus RJ
    Predictors of cardiovascular morbidities in adults with 21-hydroxylase deficiency congenital adrenal hyperplasia.
    J Clin Endocrinol Metab. 2023 Oct 25:dgad628. doi: 10.1210.
    >> Share

  19. BROOME DT
    SGLT-2 Inhibitors: Discrepancy Between MACE Reduction and Incident MI and Stroke.
    J Clin Endocrinol Metab. 2023;108:e1450-e1451.
    >> Share

  20. BOUZEMANE A, Vignot E, Dubourg LD, De Mul A, et al
    Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy.
    J Clin Endocrinol Metab. 2023 Oct 16:dgad608. doi: 10.1210.
    >> Share

    September 2023
  21. TAO X, Liu L, Ma P, Hu J, et al
    Association of Circulating Very Long Chain Saturated Fatty Acids with Cardiovascular Mortality in NHANES 2015-2016.
    J Clin Endocrinol Metab. 2023 Sep 21:dgad561. doi: 10.1210.
    >> Share

  22. ANAWALT BD
    TRAVERSING the Mountain of Ignorance: Testosterone and Cardiovascular Safety.
    J Clin Endocrinol Metab. 2023 Sep 21:dgad555. doi: 10.1210.
    >> Share

  23. SOUTH AM, Rigdon J, Voruganti S, Stafford JM, et al
    Uric Acid is Not Associated with Cardiovascular Health in Youth with Type 1 Diabetes: SEARCH for Diabetes in Youth Study.
    J Clin Endocrinol Metab. 2023 Sep 10:dgad534. doi: 10.1210.
    >> Share

    August 2023
  24. SHUFELT CL, Saadedine M, Cook-Wiens G, Pisarska MD, et al
    Functional Hypothalamic Amenorrhea and Preclinical Cardiovascular Disease.
    J Clin Endocrinol Metab. 2023 Aug 23:dgad498. doi: 10.1210.
    >> Share

  25. CHEN Z, Liu M, Xu X, He L, et al
    Serum klotho modifies the associations of 25-hydroxy vitamin D with all-cause and cardiovascular mortality.
    J Clin Endocrinol Metab. 2023 Aug 15:dgad480. doi: 10.1210.
    >> Share

  26. YUAN D, Xu N, Song Y, Zhang Z, et al
    Association Between Free Fatty Acids and Cardiometabolic Risk in Coronary Artery Disease: Results From the PROMISE Study.
    J Clin Endocrinol Metab. 2023 Aug 4:dgad416. doi: 10.1210.
    >> Share

    July 2023
  27. RAZAVI AC, Jain V, Grandhi GR, Patel P, et al
    Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?
    J Clin Endocrinol Metab. 2023 Jul 12:dgad406. doi: 10.1210.
    >> Share

  28. GURGOGLIONE FL, Pitocco D, Montone RA, Rinaldi R, et al
    Microvascular complications are associated with coronary collateralization in type 2 diabetes and chronic occlusion.
    J Clin Endocrinol Metab. 2023 Jul 7:dgad396. doi: 10.1210.
    >> Share

  29. YE B, Zhao Q, Fan J, Li X, et al
    RBP4-based multimarker score: A prognostic tool for adverse cardiovascular events in acute coronary syndrome patients.
    J Clin Endocrinol Metab. 2023 Jul 4:dgad389. doi: 10.1210.
    >> Share

  30. LOPEZ DS, Mulla JS, El Haddad D, Tahashilder MI, et al
    Testosterone replacement therapy in relation with cardiovascular disease in cisgender women and transgender people.
    J Clin Endocrinol Metab. 2023 Jul 1:dgad388. doi: 10.1210.
    >> Share

    June 2023
  31. SALAMA M, Balagopal B, Fennoy I, Kumar S, et al
    Childhood Obesity, Diabetes and Cardiovascular Disease Risk.
    J Clin Endocrinol Metab. 2023 Jun 16:dgad361. doi: 10.1210.
    >> Share

  32. OHLSSON C, Nethander M, Norlen AK, Poutanen M, et al
    Serum DHEA and Testosterone Levels Associate Inversely with Coronary Artery Calcification in Elderly Men.
    J Clin Endocrinol Metab. 2023 Jun 12:dgad351. doi: 10.1210.
    >> Share

  33. LIN X, Chen X, Liu S, Deng Y, et al
    Associations of Serum 25(OH)D with Risk of Recurrent Cardiovascular Events in Individuals with Coronary Heart Disease.
    J Clin Endocrinol Metab. 2023 Jun 6:dgad339. doi: 10.1210.
    >> Share

    May 2023
  34. SU S, Fan J, Yang Y, Yang C, et al
    Birth weight, cardiometabolic factors and coronary heart disease: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2023 May 29:dgad308. doi: 10.1210.
    >> Share

    April 2023
  35. LANG X, Zhao B, Fang S, Li L, et al
    Higher peripheral thyroid sensitivity is linked to a lower risk of heart failure after acute myocardial infarction.
    J Clin Endocrinol Metab. 2023 Apr 27:dgad240. doi: 10.1210.
    >> Share

  36. WANG C, Xin Q, Zheng M, Liu S, et al
    Association of Resting Heart Rate Trajectories with Cardiovascular Disease and Mortality in Diabetes Mellitus Patients.
    J Clin Endocrinol Metab. 2023 Apr 21:dgad228. doi: 10.1210.
    >> Share

  37. MUKAMA T, Srour B, Johnson T, Katzke V, et al
    IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all-causes in EPIC - Heidelberg.
    J Clin Endocrinol Metab. 2023 Apr 17:dgad212. doi: 10.1210.
    >> Share

  38. PEI J, Liu C, Yang Z, Lai Y, et al
    Association of KATP Variants With CMD and RAP in CAD Patients With Increased Serum Lipoprotein(a) Levels.
    J Clin Endocrinol Metab. 2023;108:1061-1074.
    >> Share

    March 2023
  39. DEI CAS A, Aldigeri R, Mantovani A, Masulli M, et al
    Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Mar 7:dgad127. doi: 10.1210.
    >> Share

    February 2023
  40. MUKHOPADHYAY P, Sanyal D, Chatterjee P, Pandit K, et al
    SGLT2 inhibitors: Effect on myocardial infarction and stroke in type 2 diabetes.
    J Clin Endocrinol Metab. 2023 Feb 28:dgad113. doi: 10.1210.
    >> Share

  41. HU T, Shen Y, Cao W, Xu Y, et al
    The association and joint effect of adipocyte fatty acid-binding protein and obesity phenotype with cardiovascular events.
    J Clin Endocrinol Metab. 2023 Feb 27:dgad110. doi: 10.1210.
    >> Share

  42. LIN J, Yang L, Huang J, Liu Y, et al
    Insulin-like Growth Factor 1 and Risk of Cardiovascular Disease: Results from the UK Biobank Cohort Study.
    J Clin Endocrinol Metab. 2023 Feb 22:dgad105. doi: 10.1210.
    >> Share

    January 2023
  43. HORTON WB, Snell-Bergeon JK
    HbA1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: the CACTI Study.
    J Clin Endocrinol Metab. 2023 Jan 13:dgad019. doi: 10.1210.
    >> Share

    December 2022
  44. GENG T, Chen JX, Zhou YF, Lu Q, et al
    Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2022 Dec 27:dgac750. doi: 10.1210.
    >> Share

    November 2022
  45. BLIUC D, Tran T, Chen W, Alarkawi D, et al
    Anti-resorptive medication use is not associated with acute cardiovascular risk: An observational study: Anti-resorptive medication and cardiovascular risk.
    J Clin Endocrinol Metab. 2022 Nov 21:dgac669. doi: 10.1210.
    >> Share

  46. YE C, Kong L, Wang Y, Lin H, et al
    Causal associations between age at diagnosis of diabetes and cardiovascular outcomes: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Nov 14. pii: 6825732. doi: 10.1210.
    >> Share

  47. BHADADA SK, Malhotra B, Shetty AJ
    Body weight variability and cardiovascular health in diabetes.
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785762. doi: 10.1210.
    >> Share

    October 2022

  48. Correction to "New Horizons: Revival of Lipoprotein (a) as a Risk Factor for Cardiovascular Disease".
    J Clin Endocrinol Metab. 2022 Oct 20. pii: 6764776. doi: 10.1210.
    >> Share

    September 2022
  49. WU VC, Peng KY, Hu YH, Chang CC, et al
    Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes.
    J Clin Endocrinol Metab. 2022 Sep 19. pii: 6705062. doi: 10.1210.
    >> Share

  50. NESTEL P, Loh WJ, Ward NC, Watts GF, et al
    New Horizons: Revival of Lipoprotein (a) as a risk factor for cardiovascular disease.
    J Clin Endocrinol Metab. 2022 Sep 15. pii: 6701631. doi: 10.1210.
    >> Share


  51. Correction to: "Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes".
    J Clin Endocrinol Metab. 2022 Sep 14. pii: 6698734. doi: 10.1210.
    >> Share

  52. LI Y, Gao R, Zhao B, Zhang Y, et al
    Low serum bicarbonate levels increased the risk of all-cause, cardiovascular and cancer Mortality in type 2 diabetes.
    J Clin Endocrinol Metab. 2022 Sep 6. pii: 6692819. doi: 10.1210.
    >> Share

  53. WEI H, Zhao M, Wu J, Li C, et al
    Association of Systemic Trimethyllysine with Heart Failure with Preserved Ejection Fraction and Cardiovascular Events.
    J Clin Endocrinol Metab. 2022 Sep 5. pii: 6691858. doi: 10.1210.
    >> Share

    August 2022
  54. DONG Y, Chen Z, Gong Y, Han Y, et al
    The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis (jc.2022-01089).
    J Clin Endocrinol Metab. 2022 Aug 16. pii: 6666536. doi: 10.1210.
    >> Share

  55. DONG Y, Chen Z, Gong Y, Han Y, et al
    The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis.
    J Clin Endocrinol Metab. 2022 Aug 15. pii: 6666536. doi: 10.1210.
    >> Share

    June 2022
  56. HOU T, Li M, Lin H, Zhao Z, et al
    The causal effect of systolic blood pressure lowering on vascular outcomes in diabetes: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Jun 15. pii: 6608757. doi: 10.1210.
    >> Share

    May 2022
  57. CHOI HR, Chang Y, Kim Y, Cho Y, et al
    Ideal cardiovascular health metrics and risk of incident early-onset vasomotor symptoms among premenopausal women.
    J Clin Endocrinol Metab. 2022 May 21. pii: 6590294. doi: 10.1210.
    >> Share

  58. LETO G, Tartaglione L, Rotondi S, Pasquali M, et al
    Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease.
    J Clin Endocrinol Metab. 2022 May 20. pii: 6590071. doi: 10.1210.
    >> Share

    April 2022
  59. CUKIERMAN-YAFFE T, Gerstein HC, Basile J, Bethel MA, et al
    Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6569991. doi: 10.1210.
    >> Share

  60. SUZUKI Y, Kaneko H, Okada A, Matsuoka S, et al
    Prediabetes in Young Adults and Its Association with Cardiovascular Health Metrics in the Progression to Diabetes.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6572042. doi: 10.1210.
    >> Share

  61. DENG X, Zhang C, Wang P, Wei W, et al
    Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes.
    J Clin Endocrinol Metab. 2022 Apr 9. pii: 6565990. doi: 10.1210.
    >> Share

    March 2022
  62. DAM V, Onland-Moret NC, Burgess S, Chirlaque MD, et al
    Genetically determined reproductive aging and coronary heart disease: a bidirectional two-sample Mendelian Randomization.
    J Clin Endocrinol Metab. 2022 Mar 20. pii: 6550950. doi: 10.1210.
    >> Share

  63. NASR A, Matthews K, Janssen I, Brooks MM, et al
    Associations of abdominal and cardiovascular adipose tissue depots with HDL metrics in midlife women: The SWAN Study.
    J Clin Endocrinol Metab. 2022 Mar 17. pii: 6550277. doi: 10.1210.
    >> Share

  64. JIANG W, Song Q, Zhang J, Chen Y, et al
    The Association of Consumption Time for Food With Cardiovascular Disease and All-Cause Mortality Among Diabetic Patients.
    J Clin Endocrinol Metab. 2022 Mar 15. pii: 6546321. doi: 10.1210.
    >> Share

    February 2022
  65. CHEN D, Zhang Y, Yidilisi A, Xu Y, et al
    Causal associations between circulating adipokines and cardiovascular disease: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Feb 3. pii: 6521299. doi: 10.1210.
    >> Share

    November 2021
  66. YANG J, Zheng Y, Li C, Liu YP, et al
    The impact of subclinical hyperthyroidism on cardiovascular prognosis in patients undergoing PCI.
    J Clin Endocrinol Metab. 2021 Nov 29. pii: 6446179. doi: 10.1210.
    >> Share

  67. SRINIVASA S, Thomas TS, Feldpausch MN, Adler GK, et al
    Coronary Vasculature and Myocardial Structure in HIV: Physiologic Insights From the Renin-Angiotensin-Aldosterone System.
    J Clin Endocrinol Metab. 2021;106:3398-3412.
    >> Share

  68. SAATMANN N, Zaharia OP, Strassburger K, Pesta DH, et al
    Physical fitness and cardiovascular risk factors in the novel diabetes subgroups.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423502. doi: 10.1210.
    >> Share

  69. ZUO Y, Han X, Tian X, Chen S, et al
    Association of Impaired Fasting Glucose with Cardiovascular Disease in the Absence of Risk Factor.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423498. doi: 10.1210.
    >> Share

    October 2021
  70. HONG S, Park JH, Han K, Lee CB, et al
    Association between Obesity and Cardiovascular Disease in Elderly Patients with Diabetes: A Retrospective Cohort Study.
    J Clin Endocrinol Metab. 2021 Oct 1. pii: 6379050. doi: 10.1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016